Thailand Readying Clinical Research Reform, Improved IPR
Thailand appears headed for reform in areas like clinical research and is even mulling a US Bayh-Dohle-type of legislation, in addition to tax concessions, as it seeks to emerge as a hub of life sciences innovation. Top officials from Thailand’s Board of Investment and the Thailand Centre of Excellence for Life Sciences share some of the nitty-gritties on these plans with the Pink Sheet.
You may also be interested in...
Tildrakizumab debuts in Japan, marking a key milestone for Sun Pharma, though heavyweight competitors including same class rival Skyrizi are already available on the market there.
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.